Skip to main content
The BMJ logoLink to The BMJ
letter
. 1991 Nov 9;303(6811):1202–1203. doi: 10.1136/bmj.303.6811.1202-c

Orthopaedic surgeons and thromboprophylaxis.

PMCID: PMC1671491  PMID: 1747629

Full text

PDF
1202

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Fordyce M. J., Baker A. S., Staddon G. E. Efficacy of fixed minidose warfarin prophylaxis in total hip replacement. BMJ. 1991 Jul 27;303(6796):219–220. doi: 10.1136/bmj.303.6796.219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Frydman A. M., Bara L., Le Roux Y., Woler M., Chauliac F., Samama M. M. The antithrombotic activity and pharmacokinetics of enoxaparine, a low molecular weight heparin, in humans given single subcutaneous doses of 20 to 80 mg. J Clin Pharmacol. 1988 Jul;28(7):609–618. doi: 10.1002/j.1552-4604.1988.tb03184.x. [DOI] [PubMed] [Google Scholar]
  3. Hirsh J., Levine M. Prevention of venous thrombosis in patients undergoing major orthopaedic surgical procedures. Br J Clin Pract Suppl. 1989 Jan;65:2–8. [PubMed] [Google Scholar]
  4. Laverick M. D., Croal S. A., Mollan R. A. Orthopaedic surgeons and thromboprophylaxis. BMJ. 1991 Sep 7;303(6802):549–550. doi: 10.1136/bmj.303.6802.549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Leyvraz P. F., Bachmann F., Hoek J., Büller H. R., Postel M., Samama M., Vandenbroek M. D. Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin. BMJ. 1991 Sep 7;303(6802):543–548. doi: 10.1136/bmj.303.6802.543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Leyvraz P. F., Richard J., Bachmann F., Van Melle G., Treyvaud J. M., Livio J. J., Candardjis G. Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement. N Engl J Med. 1983 Oct 20;309(16):954–958. doi: 10.1056/NEJM198310203091605. [DOI] [PubMed] [Google Scholar]
  7. Planès A., Vochelle N., Fagola M. Total hip replacement and deep vein thrombosis. A venographic and necropsy study. J Bone Joint Surg Br. 1990 Jan;72(1):9–13. doi: 10.1302/0301-620X.72B1.2298803. [DOI] [PubMed] [Google Scholar]
  8. Planès A., Vochelle N., Fagola M. Total hip replacement and deep vein thrombosis. A venographic and necropsy study. J Bone Joint Surg Br. 1990 Jan;72(1):9–13. doi: 10.1302/0301-620X.72B1.2298803. [DOI] [PubMed] [Google Scholar]
  9. Turpie A. G., Levine M. N., Hirsh J., Carter C. J., Jay R. M., Powers P. J., Andrew M., Hull R. D., Gent M. A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engl J Med. 1986 Oct 9;315(15):925–929. doi: 10.1056/NEJM198610093151503. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES